Dynamic Measures of Neurochemistry in Mood Disorders.

Trial Profile

Dynamic Measures of Neurochemistry in Mood Disorders.

Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2017

At a glance

  • Drugs Bupropion (Primary) ; Sertraline (Primary)
  • Indications Depressive disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 23 Mar 2011 Planned End Date changed from 1 Jun 2010 to 1 Jun 2015 as reported by ClinicalTrials.gov.
    • 16 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top